(PAYS) Paysign - Overview
Stock: Prepaid Cards, Digital Banking, Payment Processing
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 64.2% |
| Relative Tail Risk | -11.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | 18.72 |
| Character TTM | |
|---|---|
| Beta | 1.296 |
| Beta Downside | 1.208 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.60% |
| CAGR/Max DD | 0.05 |
Description: PAYS Paysign December 28, 2025
Paysign, Inc. (NASDAQ:PAYS) is a Nevada-based fintech that designs, issues, and manages prepaid card programs and related digital-banking services for corporate, consumer, and government clients. Its platform supports a range of use-cases-including corporate rewards, employee incentives, consumer rebates, clinical-trial reimbursements, and municipal payment assistance-under the Paysign brand.
The company’s product suite combines a reloadable general-purpose debit card with a full-stack communications hub (kiosk, mobile app, two-way SMS, alerts, and a cardholder portal) and back-office processing capabilities. Paysign also operates a customer-service center that handles transaction processing, dispute resolution, and compliance monitoring for its clients.
According to its most recent Form 10-Q (Q2 2024), Paysign generated $28.4 million in revenue, up 12 % year-over-year, driven primarily by growth in its healthcare-reimbursement and municipal-rebate segments. The firm reported a gross margin of 38 % and held $18 million in cash and cash equivalents, giving it a runway of roughly 18 months without external financing. Key sector drivers include the continued shift toward digital payments (U.S. prepaid card volume grew 9 % YoY in 2023) and regulatory pressure on legacy banking channels, which create tailwinds for fintech solutions that can deliver compliant, low-cost disbursements.
For a deeper, data-driven valuation framework, you might explore the analysis tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 7.56m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -9.04 > 1.0 |
| NWC/Revenue: 25.63% < 20% (prev 20.60%; Δ 5.02% < -1%) |
| CFO/TA 0.09 > 3% & CFO 18.7m > Net Income 7.56m |
| Net Debt (-1.45m) to EBITDA (14.4m): -0.10 < 3 |
| Current Ratio: 1.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (61.8m) vs 12m ago 10.20% < -2% |
| Gross Margin: 59.82% > 18% (prev 0.53%; Δ 5929 % > 0.5%) |
| Asset Turnover: 39.78% > 50% (prev 33.82%; Δ 5.96% > 0%) |
| Interest Coverage Ratio: -3.10 > 6 (EBITDA TTM 14.4m / Interest Expense TTM -2.14m) |
Altman Z'' 1.14
| A: 0.09 (Total Current Assets 171.3m - Total Current Liabilities 152.1m) / Total Assets 209.5m |
| B: 0.07 (Retained Earnings 13.7m / Total Assets 209.5m) |
| C: 0.04 (EBIT TTM 6.64m / Avg Total Assets 188.2m) |
| D: 0.08 (Book Value of Equity 13.8m / Total Liabilities 163.8m) |
| Altman-Z'' Score: 1.14 = BB |
Beneish M -2.48
| DSRI: 1.14 (Receivables 49.6m/32.8m, Revenue 74.9m/56.5m) |
| GMI: 0.89 (GM 59.82% / 53.37%) |
| AQI: 1.59 (AQ_t 0.15 / AQ_t-1 0.09) |
| SGI: 1.33 (Revenue 74.9m / 56.5m) |
| TATA: -0.05 (NI 7.56m - CFO 18.7m) / TA 209.5m) |
| Beneish M-Score: -2.48 (Cap -4..+1) = BBB |
What is the price of PAYS shares?
Over the past week, the price has changed by -10.79%, over one month by -23.14%, over three months by -27.20% and over the past year by +37.52%.
Is PAYS a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PAYS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.3 | 148.7% |
| Analysts Target Price | 9.3 | 148.7% |
| ValueRay Target Price | 3.5 | -4.8% |
PAYS Fundamental Data Overview February 02, 2026
P/E Forward = 23.2019
P/S = 3.0653
P/B = 5.0222
Revenue TTM = 74.9m USD
EBIT TTM = 6.64m USD
EBITDA TTM = 14.4m USD
Long Term Debt = 6.08m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 583.8k USD (from shortTermDebt, last quarter)
Debt = 6.08m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.45m USD (from netDebt column, last quarter)
Enterprise Value = 228.1m USD (229.5m + Debt 6.08m - CCE 7.53m)
Interest Coverage Ratio = -3.10 (Ebit TTM 6.64m / Interest Expense TTM -2.14m)
EV/FCF = 23.19x (Enterprise Value 228.1m / FCF TTM 9.84m)
FCF Yield = 4.31% (FCF TTM 9.84m / Enterprise Value 228.1m)
FCF Margin = 13.14% (FCF TTM 9.84m / Revenue TTM 74.9m)
Net Margin = 10.10% (Net Income TTM 7.56m / Revenue TTM 74.9m)
Gross Margin = 59.82% ((Revenue TTM 74.9m - Cost of Revenue TTM 30.1m) / Revenue TTM)
Gross Margin QoQ = 56.26% (prev 61.62%)
Tobins Q-Ratio = 1.09 (Enterprise Value 228.1m / Total Assets 209.5m)
Interest Expense / Debt = 9.61% (Interest Expense 584.2k / Debt 6.08m)
Taxrate = 1.36% (30.5k / 2.25m)
NOPAT = 6.55m (EBIT 6.64m * (1 - 1.36%))
Current Ratio = 1.13 (Total Current Assets 171.3m / Total Current Liabilities 152.1m)
Debt / Equity = 0.13 (Debt 6.08m / totalStockholderEquity, last quarter 45.8m)
Debt / EBITDA = -0.10 (Net Debt -1.45m / EBITDA 14.4m)
Debt / FCF = -0.15 (Net Debt -1.45m / FCF TTM 9.84m)
Total Stockholder Equity = 39.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.02% (Net Income 7.56m / Total Assets 209.5m)
RoE = 19.18% (Net Income TTM 7.56m / Total Stockholder Equity 39.4m)
RoCE = 14.59% (EBIT 6.64m / Capital Employed (Equity 39.4m + L.T.Debt 6.08m))
RoIC = 16.61% (NOPAT 6.55m / Invested Capital 39.4m)
WACC = 10.66% (E(229.5m)/V(235.6m) * Re(10.69%) + D(6.08m)/V(235.6m) * Rd(9.61%) * (1-Tc(0.01)))
Discount Rate = 10.69% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.18%
[DCF Debug] Terminal Value 59.28% ; FCFF base≈15.1m ; Y1≈9.90m ; Y5≈4.52m
Fair Price DCF = 1.13 (EV 60.9m - Net Debt -1.45m = Equity 62.3m / Shares 55.0m; r=10.66% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 56.99 | EPS CAGR: 72.15% | SUE: -2.16 | # QB: 0
Revenue Correlation: 98.23 | Revenue CAGR: 27.18% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.07 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=0.24 | Chg30d=+0.000 | Revisions Net=-2 | Growth EPS=+44.8% | Growth Revenue=+20.6%